The invention relates to a method for predicting the likelihood that a patient who is a candidate for treatment with an erbB receptor drug will respond to said treatment, comprising determining the sequence of EGFR in a tumour sample from the patient, whereby to predict an increased likelihood of response to the erbB receptor drug.
申请公布号
WO2006103421(A2)
申请公布日期
2006.10.05
申请号
WO2006GB01136
申请日期
2006.03.29
申请人
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;ELLISON, GILLIAN;MARCH, RUTH, ELEANOR;WOOKEY, ALAN
发明人
ELLISON, GILLIAN;MARCH, RUTH, ELEANOR;WOOKEY, ALAN
